Works by Hansson, Johan

Results: 134
    1
    2
    3
    4
    5
    6
    7
    8

    Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study).

    Published in:
    Cancers, 2022, v. 14, n. 4, p. 1040, doi. 10.3390/cancers14041040
    By:
    • Naeser, Ylva;
    • Helgadottir, Hildur;
    • Hansson, Johan;
    • Ingvar, Christian;
    • Elander, Nils O.;
    • Flygare, Petra;
    • Nilsson, Cecilia;
    • Jakobsson, Frida;
    • Valachis, Antonios;
    • Papantoniou, Dimitrios;
    • Nordin Danfors, Agneta;
    • Johansson, Hemming;
    • Sundin, Anders;
    • Brandberg, Yvonne;
    • Ullenhag, Gustav J.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors.

    Published in:
    Molecular Systems Biology, 2018, v. 14, n. 3, p. 1, doi. 10.15252/msb.20177858
    By:
    • Azimi, Alireza;
    • Caramuta, Stefano;
    • Seashore‐Ludlow, Brinton;
    • Boström, Johan;
    • Robinson, Jonathan L;
    • Edfors, Fredrik;
    • Tuominen, Rainer;
    • Kemper, Kristel;
    • Krijgsman, Oscar;
    • Peeper, Daniel S;
    • Nielsen, Jens;
    • Hansson, Johan;
    • Egyhazi Brage, Suzanne;
    • Altun, Mikael;
    • Uhlen, Mathias;
    • Maddalo, Gianluca
    Publication type:
    Article
    19
    20
    21
    22

    Newtonian quantum gravity.

    Published in:
    Physics Essays, 2010, v. 23, n. 1, p. 53, doi. 10.4006/1.3291188
    By:
    • Hansson, Johan
    Publication type:
    Article
    23
    24

    PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89389-9
    By:
    • Vidarsdottir, Linda;
    • Azimi, Alireza;
    • Das, Ishani;
    • Sigvaldadottir, Ingibjorg;
    • Suryo Rahmanto, Aldwin;
    • Petri, Andreas;
    • Kauppinen, Sakari;
    • Ingvar, Christian;
    • Jönsson, Göran;
    • Olsson, Håkan;
    • Frostvik Stolt, Marianne;
    • Tuominen, Rainer;
    • Sangfelt, Olle;
    • Pokrovskaja Tamm, Katja;
    • Hansson, Johan;
    • Grandér, Dan;
    • Egyházi Brage, Suzanne;
    • Johnsson, Per
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.

    Published in:
    Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02766
    By:
    • Wickström, Stina L.;
    • Lövgren, Tanja;
    • Volkmar, Michael;
    • Reinhold, Bruce;
    • Duke-Cohan, Jonathan S.;
    • Hartmann, Laura;
    • Rebmann, Janina;
    • Mueller, Anja;
    • Melief, Jeroen;
    • Maas, Roeltje;
    • Ligtenberg, Maarten;
    • Hansson, Johan;
    • Offringa, Rienk;
    • Seliger, Barbara;
    • Poschke, Isabel;
    • Reinherz, Ellis L.;
    • Kiessling, Rolf
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies.

    Published in:
    BMC Medical Research Methodology, 2012, v. 12, n. 1, p. 116, doi. 10.1186/1471-2288-12-116
    By:
    • Raimondi, Sara;
    • Gandini, Sara;
    • Fargnoli, Maria Concetta;
    • Bagnardi, Vincenzo;
    • Maisonneuve, Patrick;
    • Specchia, Claudia;
    • Kumar, Rajiv;
    • Nagore, Eduardo;
    • Han, Jiali;
    • Hansson, Johan;
    • Kanetsky, Peter A.;
    • Ghiorzo, Paola;
    • Gruis, Nelleke A.;
    • Dwyer, Terry;
    • Blizzard, Leigh;
    • Fernandez-de-Misa, Ricardo;
    • Branicki, Wojciech;
    • Debniak, Tadeusz;
    • Morling, Niels;
    • Landi, Maria Teresa
    Publication type:
    Article
    45
    46
    47
    48
    49
    50

    Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.

    Published in:
    Human Genetics, 2016, v. 135, n. 11, p. 1241, doi. 10.1007/s00439-016-1715-1
    By:
    • Yang, Xiaohong;
    • Rotunno, Melissa;
    • Xiao, Yanzi;
    • Ingvar, Christian;
    • Helgadottir, Hildur;
    • Pastorino, Lorenza;
    • Doorn, Remco;
    • Bennett, Hunter;
    • Graham, Cole;
    • Sampson, Joshua;
    • Malasky, Michael;
    • Vogt, Aurelie;
    • Zhu, Bin;
    • Bianchi-Scarra, Giovanna;
    • Bruno, William;
    • Queirolo, Paola;
    • Fornarini, Giuseppe;
    • Hansson, Johan;
    • Tuominen, Rainer;
    • Burdett, Laurie
    Publication type:
    Article